week 2 of glp 1 Physiologic effects GLP-1 (adapted from Granata et al. [11]) Customized Compounded GLP-1 Weight Loss

In total, 7187 (9.8%) participants had a major adverse cardiovascular event, including 268 (3.7%) who were receiving GLP-1 receptor agonist and 6919 (96.3%) who were not receiving a GLP-1 receptor agonist at baseline

At PNW Optimal Health, GLP-1 therapies are prescribed only when medically appropriate and always as part of a comprehensive plan that includes nutritional guidance, activity recommendations, and behavior modification strategies

The rate of infusion does not appear to affect the degree or duration of pain relief

Animal studies show foetal harm risks like growth restriction, and the drugs pass into breast milk, potentially affecting infants

Hair loss Both rapid weight loss and nutritional restriction can trigger telogen effluvium, a type of temporary hair loss caused by metabolic stress